Milestone Pharmaceuticals Inc (MIST)

$1.51

+0.01

(+0.67%)▲

Market is closed - opens 7 PM, 04 Jun 2024

Insights on Milestone Pharmaceuticals Inc

  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 3.5M → -868.00K (in $), with an average decrease of 129.1% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 4 quarters, -16.04M → -10.35M (in $), with an average increase of 16.2% per quarter

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 72.6% return, outperforming this stock by 132.4%

  • Vs NVO

    In the last 3 years, Novo Nordisk A/s has given 235.1% return, outperforming this stock by 307.7%

Performance

  • $1.49
    $1.54
    $1.51
    downward going graph

    1.32%

    Downside

    Day's Volatility :3.25%

    Upside

    1.95%

    downward going graph
  • $1.33
    $4.10
    $1.51
    downward going graph

    11.92%

    Downside

    52 Weeks Volatility :67.56%

    Upside

    63.17%

    downward going graph

Returns

PeriodMilestone Pharmaceuticals IncIndex (Russel 2000)
3 Months
-2.58%
0.0%
6 Months
-55.46%
0.0%
1 Year
-60.88%
0.0%
3 Years
-72.6%
-22.6%

Highlights

Market Capitalization
79.9M
Book Value
$0.6
Earnings Per Share (EPS)
-1.25
Wall Street Target Price
10.25
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-33.85%
Return On Equity TTM
-117.39%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
-100.0%
Gross Profit TTM
5.0M
EBITDA
-56.0M
Diluted Eps TTM
-1.25
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.79
EPS Estimate Next Year
-1.22
EPS Estimate Current Quarter
-0.26
EPS Estimate Next Quarter
-0.26

Analyst Recommendation

Buy
    80%Buy
    20%Hold
    0
    0%Sell
Based on 10 Wall street analysts offering stock ratings for Milestone Pharmaceuticals Inc(by analysts ranked 0 to 5 stars)
Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
2
2
2
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 578.81%

Current $1.51
Target $10.25

Technicals Summary

Sell

Neutral

Buy

Milestone Pharmaceuticals Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Milestone Pharmaceuticals Inc
Milestone Pharmaceuticals Inc
-13.22%
-55.46%
-60.88%
-72.6%
-92.6%
Moderna, Inc.
Moderna, Inc.
21.03%
85.08%
14.68%
-28.27%
659.22%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
3.22%
20.18%
31.88%
93.3%
227.58%
Novo Nordisk A/s
Novo Nordisk A/s
8.85%
34.38%
71.83%
235.07%
463.44%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
16.81%
34.1%
40.6%
123.97%
174.53%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Milestone Pharmaceuticals Inc
Milestone Pharmaceuticals Inc
NA
NA
NA
-0.79
-1.17
-0.34
NA
0.6
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.14
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
28.89
28.89
1.46
44.13
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
46.97
46.97
2.36
3.5
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
29.59
29.59
0.53
17.08
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Milestone Pharmaceuticals Inc
Milestone Pharmaceuticals Inc
Buy
$79.9M
-92.6%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$54.6B
659.22%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$108.0B
227.58%
28.89
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$602.6B
463.44%
46.97
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$117.5B
174.53%
29.59
39.46%

Institutional Holdings

  • BlackRock Inc

    9.33%

  • RTW INVESTMENTS, LLC

    6.11%

  • Millennium Management LLC

    5.36%

  • Alta Fundamental Advisers LLC

    4.45%

  • Lion Point Capital, LP

    4.32%

  • Orbimed Advisors, LLC

    3.76%

Company Information

milestone pharmaceuticals is a biotechnology company located in 6100 royalmount ave, montreal, qc, canada.

Organization
Milestone Pharmaceuticals Inc
Employees
47
CEO
Mr. Joseph G. Oliveto M.B.A.
Industry
Pharmaceuticals: Major

Discover More

FAQs